Patent details

EP3521312 Title: A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA

Basic Information

Publication number:
EP3521312
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP191634757
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA
French Title of Invention:
COMPOSÉ QUI SE LIE SPÉCIFIQUEMENT À KIR3DL2 DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DU LYMPHOME T PÉRIPHÉRIQUE
German Title of Invention:
VERBINDUNG MIT SPEZIFISCHER BINDUNG AN KIR3DL2 ZUR VERWENDUNG BEI DER BEHANDLUNG VON PERIPHEREM T-ZELL-LYMPHOM
SPC Number:

Dates

Filing date:
20/02/2014
Grant date:
07/04/2021
EP Publication Date:
07/08/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/04/2021
EP B1 Publication Date:
07/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/02/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/03/2021
 
 

Name:
Innate Pharma
Address:
117 Avenue de Luminy, 13009 Marseille, France (FR)

Inventor

1

Name:
BUFFET, Renaud
Address:
France (FR)

2

Name:
SICARD, Hélène
Address:
France (FR)

3

Name:
BONNAFOUS, Cécile
Address:
France (FR)

Priority

1

Priority Number:
201361766798 P
Priority Date:
20/02/2013
Priority Country:
United States (US)

2

Priority Number:
201361831809 P
Priority Date:
06/06/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61P 35/00; C07K 16/28; C07K 16/30;

Publication

European Patent Bulletin

1

Issue number:
202114
Publication date:
07/04/2021
Description:
Grant (B1)

2

Issue number:
202119
Publication date:
12/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/03/2027
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2026
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages